Publications by authors named "Eva Larde"

Claim this Profile
T
Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
Elodie Pramil, Linda Herbi Bastian, Thomas Denèfle, Fariba Nemati, Malina Xiao

Blood Adv· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells.
Thomas Denèfle, Elodie Pramil, Luis Gómez-Morales, Mikail D Levasseur, Eva Lardé

J Med Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer.
Justine Bellier, Marie-Julie Nokin, Eva Lardé, Philippe Karoyan, Olivier Peulen

Diabetes Res Clin Pract· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells.
Ashanti Concepción Uscanga-Palomeque, Kenny Misael Calvillo-Rodríguez, Luis Gómez-Morales, Eva Lardé, Thomas Denèfle

Cancer Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure-Activity Relationship Studies.
Thomas Denèfle, Héloise Boullet, Linda Herbi, Clara Newton, Ana-Carolina Martinez-Torres

J Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis